2014
DOI: 10.1007/s10620-014-3171-x
|View full text |Cite
|
Sign up to set email alerts
|

Role of SpyGlass Peroral Cholangioscopy in the Evaluation of Indeterminate Biliary Lesions

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
53
0
3

Year Published

2015
2015
2021
2021

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 64 publications
(57 citation statements)
references
References 23 publications
1
53
0
3
Order By: Relevance
“…The diagnostic yield of TB under SOCS in the current study was comparable to that reported by previous studies [11][12][13][14][15][16][17][18][19]. Many of the previous reports noted that more than three tissue samples were required for an accurate diagnosis, as the relatively small tissue samples obtained by SpyBite  rendered pathological examination challenging.…”
Section: Discussionsupporting
confidence: 87%
See 1 more Smart Citation
“…The diagnostic yield of TB under SOCS in the current study was comparable to that reported by previous studies [11][12][13][14][15][16][17][18][19]. Many of the previous reports noted that more than three tissue samples were required for an accurate diagnosis, as the relatively small tissue samples obtained by SpyBite  rendered pathological examination challenging.…”
Section: Discussionsupporting
confidence: 87%
“…The SpyGlass  system by Boston Scientific is a recently launched single-operator cholangioscopy (SOCS) [10]. The sensitivity, specificity, and accuracy of targeted biopsy (TB) of biliary strictures using SpyGlass  were reported as 49-88%, 82-100%, and 25-88%, respectively [11][12][13][14][15][16][17][18][19]. However, a meta-analysis showed that the sensitivity of the SpyGlass  system was only moderate; thus, its diagnostic value requires improvement [20].…”
Section: Introductionmentioning
confidence: 99%
“…In fact, the cholangiopancreatoscopy with SpyGlass® has demonstrated promising results in an international multicenter study [3], and was approved by the US Food and Drug Administration in 2009 for diagnostic and therapeutic applications during endoscopic procedures in the pancreatobiliary system [4].…”
Section: Introductionmentioning
confidence: 99%
“…23 Many studies have reported the characteristics of SOC, although they are mostly observational in nature and performed using the first generation SpyGlass device (Table 2). 3,[24][25][26][27][28][29][30][31][32] The largest study was a 2011 prospective cohort study including 15 referral centers in the United States and Europe. This study included 297 patients, with 226 who underwent SOC for diagnosis of suspected bile duct disease and 95 who received biopsies for sensitivity and specificity analysis.…”
Section: Single-operator Cholangioscopymentioning
confidence: 99%